Development of Glucagon-Like Peptide 1 Receptor Agonists for the Management of Obesity Glucagon-like peptide 1 receptor agonists (GLP-1RAs), including liraglutide and semaglutide, were initially developed for the treatment of type 2 diabetes but were found to be effective not only in reducing blood glucose levels but body weight as well [18,19,20]
Practical Strategies to Reduce Nausea and Vomiting Eat smaller, lighter meals and avoid high-fat, greasy, or spicy foods during your first 23 weeks on semaglutide
Reduced risk of developing type 2 diabetes among patients using GLP-1 medication, compared to those using a placebo
GLP-1s currently used for weight lossalthough not all are expressly approved for this purposeinclude Ozempic and Wegovy (semaglutide)
Although there is no direct evidence linking GLP-1 use to worsening glaucoma or prior optic nerve disease, Dr
People taking orforglipron do not need to restrict food or drink after taking the pill, says Skovronsky